March 22, 2019
H.C. WAINWRIGHT & CO.
Price Target A$2.00
"FUJIFILM Delay Merely a Bump in the Road, We Believe; Reiterate Buy"
"This week, CynataTherapeutics announced that it had granted a six-month extension ofthe option exercise period to its partner, FUJIFILM, following a requestfrom the Japanese firm to permit additional time for legal review to takeplace."
"we believe that the six-month extension is not indicative ofa reduced likelihood of option exercise."
"Cynatamanagement indicated at a conference in New York this week that aPhase 2 trial of CYP-001 in graft-vs.-host disease (GvHD) should stillstart enrollment this year."
"We alsoanticipate that Cynata may enter at least one other clinical indicationwith its Cymerus™ technology platform this year.'
"Our valuation translates into aprice objective of roughly A$2.00 per share, based on 103M fully-dilutedshares outstanding as of end-fiscal 2019 (calendar mid-2019)."
http://files.cynata.com/474/Cynata-Therapeutics-%28CYP-AU%29_22Mar19-Update.pdf
Ann: Cynata Extends FUJIFILM Licence Option in GvHD, page-243
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $44.90M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 25.0¢ | 25.0¢ | $3.097K | 12.38K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 29341 | 25.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.5¢ | 11015 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| CYP (ASX) Chart |